Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab

BACKGROUND/AIMS: The aim of our study was to determine the incidence and clinical features of severe pulmonary complications in patients receiving cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or rituximab plus CHOP (R-CHOP) as the initial treatment for lymphoma. METHODS: A retro...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Lim, Kyu-Hyoung, Yoon, Ho-Il, Kang, Young Ae, Lee, Keun-Wook, Kim, Jee Hyun, Bang, Soo-Mee, Lee, Jae Ho, Lee, Choon-Taek, Lee, Jong Seok
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: The Korean Association of Internal Medicine 2010
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2829422/
https://ncbi.nlm.nih.gov/pubmed/20195409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2010.25.1.86
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items